Cancer multidrug resistance

Name: Cancer multidrug resistance
Creator: A, Persidis
Keywords: 0301 basic medicine, Clinical Trials as Topic, 0303 health sciences, Drug Industry, Research, Antineoplastic Agents, Drug Resistance, Multiple, 03 medical and health sciences, Drug Resistance, Neoplasm, Humans

A, Persidis

Found an issue? Give us feedback

Nature Biotechnologyarrow_drop_down

Nature Biotechnology

Article . 1999 . Peer-reviewed

License: Springer TDM

Data sources: Crossref

Nature Biotechnology

Article . 1999

Data sources: Europe PubMed Central

https://dx.doi.org/10.1038/528...

Article

Data sources: Microsoft Academic Graph

Cancer multidrug resistance

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1999 English Publisher:Springer Science and Business Media LLCJournal:Nature Biotechnology, volume 17, pages 94-95 (issn: 1087-0156, eissn: 1546-1696,

Copyright policy )

Authors: A, Persidis;

doi: 10.1038/5289

pmid: 9920278

Cancer multidrug resistance

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Clinical Trials as Topic, Drug Industry, Research, Antineoplastic Agents, Drug Resistance, Multiple, Drug Resistance, Neoplasm, Humans, ATP-Binding Cassette Transporters, ATP Binding Cassette Transporter, Subfamily B, Member 1, Multidrug Resistance-Associated Proteins, Forecasting

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	309
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%